This is what the selling yesterday would have been about. People thinking that todays webinar would be in conjunction with a Capital Raise. People trying to outsmart the market.
.............
I don't think people realise just how complex a combination product technegas is and why the FDA had given it a CRL in 2021 so that company could provide more information. It's not that management can't execute! The cost of funding a trial always takes millions and millions, if not tens of millions of dollars to complete.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)